Northwestern Mutual Wealth Management Co. cut its holdings in shares of CME Group Inc (NASDAQ:CME) by 64.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,873 shares of the financial services provider’s stock after selling 7,026 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in CME Group were worth $635,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CME. Dupont Capital Management Corp grew its position in shares of CME Group by 30.7% during the first quarter. Dupont Capital Management Corp now owns 2,549 shares of the financial services provider’s stock worth $412,000 after buying an additional 599 shares in the last quarter. Parametrica Management Ltd acquired a new position in shares of CME Group during the first quarter worth about $235,000. Victory Capital Management Inc. grew its position in shares of CME Group by 7.8% during the first quarter. Victory Capital Management Inc. now owns 94,961 shares of the financial services provider’s stock worth $15,359,000 after buying an additional 6,867 shares in the last quarter. D.A. Davidson & CO. grew its position in shares of CME Group by 1.3% during the first quarter. D.A. Davidson & CO. now owns 26,673 shares of the financial services provider’s stock worth $4,314,000 after buying an additional 350 shares in the last quarter. Finally, Quantitative Systematic Strategies LLC acquired a new position in shares of CME Group during the first quarter worth about $518,000. Institutional investors own 84.03% of the company’s stock.

A number of equities analysts have recently commented on CME shares. Jefferies Financial Group reissued a “buy” rating and set a $190.00 price objective on shares of CME Group in a research report on Wednesday. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, August 22nd. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, June 6th. Wells Fargo & Co boosted their price objective on CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a research report on Monday, July 9th. Finally, Rosenblatt Securities started coverage on CME Group in a research report on Wednesday. They set a “neutral” rating and a $177.00 price objective for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $174.40.

In related news, Director Jeffrey M. Bernacchi sold 4,976 shares of the company’s stock in a transaction that occurred on Tuesday, September 4th. The stock was sold at an average price of $176.60, for a total value of $878,761.60. Following the completion of the transaction, the director now directly owns 52,004 shares of the company’s stock, valued at $9,183,906.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction that occurred on Tuesday, July 10th. The shares were sold at an average price of $164.11, for a total value of $410,275.00. Following the completion of the sale, the chief financial officer now directly owns 32,457 shares of the company’s stock, valued at $5,326,518.27. The disclosure for this sale can be found here. Insiders sold 21,068 shares of company stock valued at $3,515,059 over the last ninety days. 0.57% of the stock is currently owned by corporate insiders.

Shares of CME opened at $173.50 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.08 and a quick ratio of 1.08. The company has a market capitalization of $58.16 billion, a P/E ratio of 28.98, a price-to-earnings-growth ratio of 3.21 and a beta of 0.64. CME Group Inc has a 52-week low of $124.92 and a 52-week high of $177.35.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.22 earnings per share. sell-side analysts predict that CME Group Inc will post 6.68 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 25th. Investors of record on Monday, September 10th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date of this dividend is Friday, September 7th. CME Group’s dividend payout ratio (DPR) is 58.70%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: Moving Average (MA)

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.